semaglutide cause depression Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database Safety Update on GLP-1 RA

Abstract: The BPC-157 peptide, demonstrating a broad spectrum of action, is also used in the proper functioning of the cardiovascular system

As experts gather more data, the ability to tailor GLP-1 treatment based on precise hormonal, genetic, and metabolic information will define the next standard of care, ensuring safety and maximizing long-term outcomes through the midlife transition and beyond.

Consent for publication Written informed consent to publish the information was obtained from the study participant

While newer medications like tirzepatide may produce greater early weight loss for some, semaglutide remains a well-established, highly effective option for long-term weight management

fumigatus egtA AfS77